CTX-112 is a gene-modified cell therapy commercialized by CRISPR Therapeutics, w...
Influenza (quadrivalent) vaccine is a mrna vaccine commercialized by Pfizer, wit...
RL-007 is a small molecule commercialized by Atai Life Sciences, with a leading ...
FLT-201 is a gene therapy commercialized by Spur Therapeutics, with a leading Ph...
PF-07264660 is a monoclonal antibody commercialized by Pfizer, with a leading Ph...
On 17 June, Amylyx acquired the rights to Eiger Biopharmaceutical’s experimental...
Hong Kong King-Friend Industrial has acquired worldwide rights to Yusimry, and i...
Though downsized, Alumis still clocked one of the largest IPOs within the biotec...
Holoclara has secured $16m in a Series A financing to advance new worm-derived t...
Eisai and Biogen have announced the introduction of LEQEMBI (lecanemab) for the ...
Nearly 200 people have been charged with participating in healthcare fraud schem...
The US Supreme Court blocked $6bn opioid crisis settlement that would have shiel...
NovoNordisk acquired the hypertension and kidney disease drug ocedurenone from K...
